CCN2 (connective tissue growth factor [CTGF]/hypertrophic chondrocyte-specific gene product 24 [Hcs24]) is a cysteine-rich secretory protein of 36 to 38 kDa that has four distinct modules; that is, the insulin-like growth factor-binding protein-like, von Willebrand factor type C repeat, thrombospondin type 1 repeat, and C-terminal modules (Leask and Abraham 2006). Although the regulation of CCN2 has been principally found to occur at the level of gene transcription (Grotendorst et al. 1996; Holmes et al. 2001; Leask et al. 2001), it has also been established that, inc chondrocytes, the CCN2 gene can also be regulated by elements in its 3′ untranslated region (3′-UTR) at posttranscriptional stages (Kondo et al. 2000). Indeed, a cis element in the 3′-UTR of chicken ccn2 mRNA plays an important role in CCN2 regulation in chondrocytes (Mukodai et al. 2005).

The 3′ UTR has for quite some time been recognized as being responsible for positioning mRNAs in particular portions of the cell and hence controlling the location of RNA translation, especially in terms of the Drosophila oocyte (Macdonald and Struhl 1988; Macdonald et al. 1993). It is now accepted that the 3′ UTR is generally required for placing mRNAs in subcellular compartments, and hence acts as a sort of ZIP code containing specific cis elements which can bind trans-acting factors which act to position mRNAs in cells. Such mechanisms involve the use of molecular motors such as dynein to shuttle mRNAs along microtubules (Epstein et al. 2000).

Nucleophosmin (NPM) is an abundantly expressed multifunctional nucleolar phosphoprotein. A unified mechanism for NPM’s role in cell growth has recently been proposed; namely, that NPM directs the nuclear export of both 40S and 60S ribosomal subunits (Maggi et al. 2008). Transduction of NPM shuttling-defective mutants or loss of Npm1, inhibits nuclear export of both the 40S and 60S ribosomal subunits, reduces the available pool of cytoplasmic polysomes, and diminishes overall protein synthesis without affecting rRNA processing or ribosome assembly.

In a recent report, Mukudai et al. (2008) finally purified and identified this trans-factor protein binding the minimal repressive cis element in the 3′-UTR of ccn2 mRNA as NPM. With recombinant NPM protein, the authors were able to reproduce the posttranscriptional regulatory events in vitro that were observed during endochondral ossification in vivo. Alteration of nucleocytoplasmic shuttling of the trans factor was critical for the regulation of chicken ccn2 expression (Mukudai et al. 2008). The destabilization effect of NPM on ccn2 mRNA is more specific and robust in chondrocytes that in other cell types, suggesting that other proteins are in fact actually responsible for the stability of the CCN2 mRNA. These results suggest that NPM may normally act to shuttle RNAs and ribosomal subunits to the cytosol, possibly by interacting with cis acting sequences on the 3′-UTRs of RNA. However, NPM presumably has additional functions, and can possibly act to by bring in additional protein to RNAs.

To my knowledge, no study concerning the role of NPM in skeletal development has previously appeared in the literature; thus, the findings of Mukudai et al. (2008) appear to represent the first report of a novel NPM-mediated gene regulation system critical for proper chondrogenesis and endochondral ossification. The next goal of this laboratory is presumably to uncover the precise regulatory mechanism underlying the degradation of ccn2 mRNA mediated by the interaction among its 3’-UTR and NPM, including any other factor(s) that needs to be identified.